Literature DB >> 1386291

Plasma atrial natriuretic peptide is unstable under most storage conditions.

R A Nelesen1, J E Dimsdale, M G Ziegler.   

Abstract

BACKGROUND: Atrial natriuretic peptide (ANP) is a hormonal regulator of cardiovascular fluid volume. More than 1,000 scientific articles were written about ANP between 1987 and 1991. Because some articles hinted at problems with storing ANP, this study examined the effect of numerous techniques for storing and processing human ANP samples. METHODS AND
RESULTS: Samples were obtained repeatedly from three patients, treated, and stored under a variety of conditions. Experiment 1 evaluated the effects of different preservatives at 35, 21, 14, 10, and 7 days before assay. Experiment 2 evaluated nonspecific binding of ANP to different storage tubes during 28 days of storage. Experiment 3 evaluated the effect of storage at -20 degrees C, -80 degrees C, and -196 degrees C for 1 month. ANP was very unstable, degrading as much as 30% after 3 days of storage and by more than 50% in 1 month even when stored at -80 degrees C. Only storage at -196 degrees C (in liquid nitrogen) kept ANP stable for 1 month. Extraction and lyophilization of the samples before freezing and assay within 7 days of freezing only partially minimized the amount of degradation. All other processing techniques had little effect on slowing the degradation of ANP.
CONCLUSIONS: These findings raise disturbing questions about the interpretation of the substantial literature on ANP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386291     DOI: 10.1161/01.cir.86.2.463

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  Fish oil and ischaemic heart disease.

Authors:  S D Kristensen; R De Caterina; E B Schmidt; S Endres
Journal:  Br Heart J       Date:  1993-09

2.  Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.

Authors:  J G Cleland; S Ward; D Dutka; F Habib; M Impallomeni; I J Morton
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

3.  Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Authors:  G Jakob; J Mair; M Pichler; B Puschendorf
Journal:  Br Heart J       Date:  1995-02

4.  Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.

Authors:  Yan Jiang; Joel Castro; Linda V Blomster; Akello J Agwa; Jessica Maddern; Gudrun Schober; Volker Herzig; Chun Yuen Chow; Fernanda C Cardoso; Paula Demétrio De Souza França; Junior Gonzales; Christina I Schroeder; Steffen Esche; Thomas Reiner; Stuart M Brierley; Glenn F King
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

5.  Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans.

Authors:  Nora E Zois; Dijana Terzic; Kristine Færch; Peter Plomgaard; Jakob S Hansen; Peter Rossing; Jens P Goetze
Journal:  EBioMedicine       Date:  2017-03-01       Impact factor: 8.143

6.  RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.

Authors:  Estefanía Tarazón; Esther Roselló-Lletí; Miguel Rivera; Ana Ortega; Maria Micaela Molina-Navarro; Juan Carlos Triviño; Francisca Lago; José Ramón González-Juanatey; Placido Orosa; José Anastasio Montero; Antonio Salvador; Manuel Portolés
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.